ClearPoint Neuro (CLPT) Total Debt Growth (1y) (2012 - 2023)
ClearPoint Neuro (CLPT) Total Debt Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 19.06% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -5.48% |
| 10 | ClearPoint Neuro | 524.46 Mn | 488.86 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 0.57% |
| Sep 30, 2023 | 0.57% |
| Jun 30, 2023 | 0.57% |
| Mar 31, 2023 | 0.57% |
| Dec 31, 2022 | 0.56% |
| Sep 30, 2022 | -43.91% |
| Jun 30, 2022 | -43.64% |
| Mar 31, 2022 | -59.82% |
| Dec 31, 2021 | -60.65% |
| Sep 30, 2021 | 1,865.74% |
| Jun 30, 2021 | 1,853.57% |
| Mar 31, 2021 | 40.09% |
| Dec 31, 2020 | 1,105.98% |
| Sep 30, 2020 | -52.02% |
| Jun 30, 2020 | -52.06% |
| Mar 31, 2020 | 799.80% |
| Dec 31, 2019 | 6.86% |
| Sep 30, 2019 | -3.49% |
| Jun 30, 2019 | 43.94% |
| Mar 31, 2019 | 63.47% |